Tracer library / [68Ga]Ga-OncoFAP-NODAGA
[68Ga]Ga-OncoFAP-NODAGA
Also written as [68Ga]Ga-OncoFAP-NODAGA; [Ga-68]Ga-OncoFAP-NODAGA
- Radionuclide
- Ga-68 t½ 67.7 min
- Modality
- PET
- Production route
- Generator
- Stage
- Research
- Syntheses indexed
- 0
What it is
- Compound class
- Small molecule chelate
- Target / mechanism
- FAP PMID 34957527 / DOI 10.1007/s00259-021-05653-0
- Clinical application
- —
- Theranostic pair
- —
Regulatory status
- FDA
- No Drugs@FDA / openFDA drug registry — no approved application found; search: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=BasicSearch.process&searchTerm=OncoFAP
- EMA (centralised)
- —
- Other approvals
- —
- Brand names
- —
Published syntheses
No synthesis has been parsed for this agent yet.
Precursor
- Common precursor
- NODAGA-OncoFAP conjugate (from OncoFAP-COOH) PMID 36015106 / DOI 10.3390/ph15080958
- Suppliers seen in the literature
- —
- Typical final purification
- SPE
Need this precursor?We can point you to suppliers for [68Ga]Ga-OncoFAP-NODAGA, or handle the enquiry for you.
Get in touchQuality control Preliminary - inferred from compound class
- Ph. Eur. monograph
- not verified No Ph. Eur. check is recorded for this entry.
- USP monograph
- not verified No USP check is recorded for this entry.
How this set was arrived at. base set per Ph. Eur. general monograph 0125 (rule); radiometal tracer -> metal impurities (rule); Ga-68, generator production assumed (no synthesis data found) -> Ge-68 breakthrough (preliminary); receptor ligand with a saturable target -> molar activity (rule)
Tests listed by reference only. Monograph texts are copyrighted and are not reproduced here. How these are derived
Setting up quality control?We can help you scope the equipment needed to release [68Ga]Ga-OncoFAP-NODAGA.
Get in touch